Breathe Well-being

breathewellbeing.in →

-78%

est. 2Y upside i

Series A

A digital well-being program to help people prevent or manage chronic…

Rank

#3413

Sector

Digital Therapeutics

Est. Liquidity

~4Y

Data Quality

Data: Medium

Breathe Well-being presents a risky equity opportunity for a job seeker.

Last updated: March 10, 2026

Bull (10%)+300%

Breathe Well-being leverages its clinically proven digital therapeutics program and personalized coaching to significantly expand its market share in India and potentially other emerging markets. Strategic partnerships with large healthcare providers or insurers drive rapid customer acquisition, pushing revenue to $150M+ by 2028 and justifying a $200M+ valuation at a healthy multiple, leading to a successful acquisition.

Base (45%)+50%

The company continues to grow steadily within the Indian digital diabetes management market, maintaining its competitive position through strong user engagement and clinical outcomes. Revenue reaches approximately $50M by 2028, leading to an acquisition at a $75M valuation, providing a modest return for common shareholders after accounting for liquidation preferences.

Bear (45%)-80%

Increased competition from well-funded incumbents like UnitedHealthcare's Level2 and other digital health platforms, combined with the impact of the 2025 layoffs, stifles growth and market penetration. The company struggles to secure further funding at a favorable valuation, leading to a distressed acquisition or down round at a valuation below $20M, effectively wiping out most common stock value due to liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Investors hold $13M in liquidation preferences. In an exit at the estimated $50M valuation, common shareholders would receive $37M distributed among them. If the exit is below $13M, common shareholders would receive nothing.

Dilution Risk

high

As a Series A company, Breathe Well-being will likely require at least one to two more significant funding rounds (Series B, C) before a liquidity event, leading to further dilution for existing equity holders.

Secondary Liquidity

limited

Accredited investors may be able to buy pre-IPO shares through platforms like EquityZen, but there is no active or broad secondary market for employee shares.

View all 3 open roles at Breathe Well-being →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Breathe Well-being's data — designed to show you've done your homework.

  • 1

    “Given the reported layoffs in January 2025, how has the company restructured its operations and what are the key strategic priorities for the next 12-24 months to ensure sustainable growth?”

  • 2

    “With dominant incumbents like UnitedHealthcare's Level2 actively competing, what specific strategies is Breathe Well-being implementing to defend and expand its market position, particularly in terms of product differentiation and customer acquisition?”

  • 3

    “As a Series A company, what is the anticipated timeline and strategy for future funding rounds, and how is the company planning to manage potential dilution for employees holding equity?”

Community

Valuation Sentiment

Our model estimates -78% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.